I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| mast cell | 16 studies | 36% ± 13% | |
| endothelial cell | 12 studies | 29% ± 10% | |
| macrophage | 12 studies | 30% ± 15% | |
| microglial cell | 9 studies | 32% ± 12% | |
| epithelial cell | 8 studies | 31% ± 17% | |
| ciliated cell | 8 studies | 21% ± 6% | |
| dendritic cell | 8 studies | 27% ± 8% | |
| natural killer cell | 6 studies | 21% ± 3% | |
| myeloid cell | 6 studies | 27% ± 8% | |
| club cell | 6 studies | 21% ± 6% | |
| T cell | 6 studies | 21% ± 4% | |
| non-classical monocyte | 5 studies | 21% ± 5% | |
| basal cell | 5 studies | 30% ± 19% | |
| CD8-positive, alpha-beta T cell | 5 studies | 19% ± 3% | |
| astrocyte | 5 studies | 24% ± 7% | |
| monocyte | 5 studies | 32% ± 9% | |
| type II pneumocyte | 5 studies | 21% ± 6% | |
| classical monocyte | 4 studies | 21% ± 5% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 19% ± 5% | |
| lymphocyte | 4 studies | 34% ± 15% | |
| respiratory goblet cell | 4 studies | 26% ± 9% | |
| adipocyte | 4 studies | 18% ± 2% | |
| alveolar macrophage | 4 studies | 38% ± 15% | |
| endothelial cell of lymphatic vessel | 4 studies | 25% ± 4% | |
| fibroblast | 4 studies | 24% ± 3% | |
| type I pneumocyte | 4 studies | 24% ± 8% | |
| oligodendrocyte | 4 studies | 24% ± 3% | |
| hematopoietic precursor cell | 3 studies | 21% ± 5% | |
| B cell | 3 studies | 18% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 23% ± 4% | |
| CD4-positive, alpha-beta T cell | 3 studies | 26% ± 5% | |
| mononuclear phagocyte | 3 studies | 22% ± 6% | |
| mucosal invariant T cell | 3 studies | 23% ± 5% | |
| hepatocyte | 3 studies | 48% ± 30% | |
| goblet cell | 3 studies | 30% ± 17% | |
| mucus secreting cell | 3 studies | 22% ± 5% |
